Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: buy #'s

buy #'s

posted on Sep 28, 2007 05:29AM

from 10k 

As part of the program we purchased 13,467,527 shares of our common stock at an aggregate cost of $8,832,078 during the year ended May 31, 2007.

from yesterdays filing

To date we’ve acquired more than 18 million of our own shares under a program that began back in July of 2006  = 4.5 to 5.5 million purchased... average price we can not figure out... becuase they say 8.8 million spent which was the same # given in the 10k
Share
New Message
Please login to post a reply